Overall, the prevalence of arterial thrombotic events in patients with VWD was reported to be 39%-63% lower than in the general population [5].​​ For VTE, elevated VWF levels increase the risk of VTE and long-term venous complications [6]. The gene discussed is VWF; the disease is von Willebrand disease (hereditary or acquired).